TP53 and hepatocellular carcinoma: For instance, PRIM1 can be used for predicting HCC prognosis, and its upregulation accelerates HCC progression through activation of the AKT/mTOR pathway and UBE2C-induced P53 ubiquitination (Zhu et al., 2021).